Clinical and quantitative coronary angiographic predictors of coronary restenosis: A comparative analysis from the balloon-to-stent era

Journal of the American College of Cardiology

Volumn 38, Issue 3, 2001, Pages 645-652

  Mercado, Nestor ^a   Boersma, Eric ^a   Wijns, William ^b   Gersh, Bernard J ^c   Morillo, Carlos A ^d   De Valk, Vincent ^f   Van Es, Gerrit Anne ^f   Grobbee, Diederick E ^e   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIOVASCULAR CENTER   (Belgium)

^c MAYO CLINIC   (United States)

^d Laboratory of Autonomic Physiology and Electrophysiology   (Colombia)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f CARDIALYSIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; STENTS;

EID: 0034841496     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01431-0     Document Type: Article

References (51)

1. Can restenosis after coronary angioplasy be predicted from clinical variables?
2. Predictive factors of restenosis after coronary stent placement
3. Predictors of restenosis after coronary stent implantation
4. Vessel size and long-term outcome after coronary stent placement
5. Influence of lesion length on restenosis after coronary stent placement
6. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: Results of a meta-analysis of the BElgian NEtherlands STENT-I (BENESTENT-I) study, BENESTENT-II pilot, BENESTENT-II and Multicenter Ultrasound Stent In Coronaries (MUSIC) trials
7. Reference chart derived from post-stent implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography
8. Prediction of restenosis after coronary balloon angioplasty: Results of the Post-IntraCoronary Treatment Ultrasound Result Evaluation (PICTURE), a prospective multicenter intracoronary ultrasound imaging study
9. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study
10. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study
11. 2 antagonism (CARPORT) study
12. Does the new angiotensin-converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind, placebo-controlled trial
13. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty: A multicenter randomized double-blind placebo-controlled trial
14. Effect of high-dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study - A multicenter, double-blind, placebo-controlled trial of cilazapril
15. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty: Final results of the FLuvastatin Angiographic REstenosis (FLARE) trial
16. TRAPIST study: A randomized double-blind study to evaluate the efficacy of trapidil on restenosis after successful elective coronary stenting
17. Heparin-coated Palmaz-schatz stents in human coronary arteries: Early outcome of the Benestent-II pilot study
18. Stent implantation in acute myocardial infarction using a heparin-coated stent: A pilot study as a preamble to a randomized trial comparing balloon angioplasty and stenting
19. Clinical and angiographic results with the Multi-Link Coronary Stent System: The West European Stent Trial (WEST)
20. Clinical and angiographic results with the Multi-Link stent implanted under intravascular ultrasound guidance (WEST-2 study)
21. Clinical and quantitative angiographic outcomes following elective implantation of the self-expanding Wallstent for longer coronary artery lesions: Final results of the Wallstent native study
22. Clinical and angiographic results with the beStent
23. Clinical and angiographic results with the ACS MULTI-LINK DUET coronary stent system: The DUET study
24. Angiographic and clinical one-year follow-up of the Cordis tantalum coil stent in a multicenter international study demonstrating improved restenosis rates when compared to pooled PTCA and BENESTENT-I data: The European Antiplatelet Stent Investigation (EASI)
25. Multicentre open evaluation of the phosphorylcholine-coated biodivYsio stent in native de novo coronary lesions: The SOPHOS study
26. The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions: Final results of the Magic 5L Study
27. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease
28. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (BENESTENT II)
29. Coronary angioplasty with or without stent implantation for acute myocardial infarction
30. Experimental validation of geometric and densitometric coronary measurements on the new-generation Cardiovascular Angiography Analysis System (CAAS II)
31. Defining coronary restenosis: Newer clinical and angiographic paradigms
32. Coronary angiography and cardiac catheterization
33. QCA: Technical update 1995
34. Information theory as an extension of the maximum likelihood principle
35. Influence of diabetes mellitus on early and late outcomes after percutaneous transluminal coronary angioplasty
36. Increased restenosis in diabetes meilitus after coronary interventions is due to exaggerated intimal hyperplasia: A serial intravascular ultrasound study
37. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels
38. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: A potential factor predisposing to thrombosis and its persistence
39. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients
40. Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty: A quantitative angiographic analysis of 3,336 lesions
41. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina
42. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
43. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting
44. Luminal narrowing after percutaneous transluminal coronary angioplasty: A study of clinical, procedural, and lesional factors related to long-term angiographic outcome
45. Stented segment length as an independent predictor of restenosis
46. Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials)
47. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty
48. Lack of neointimal prolifera after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study